Form 4: Thermo Fisher Scientific CEO Marc Casper Executes Stock Option and Sells Shares Under 10b5-1 Plan

Thermo Fisher Scientific's CEO, Marc Casper, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Marc N. Casper, Chairman & CEO of Thermo Fisher Scientific, executed stock options and sold shares of common stock on June 3 and June 4, 2024.
• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on November 10, 2023.
• On June 3, 2024, Casper exercised options to acquire 10,000 shares at a price of $190.59 per share and sold 9,941 shares at weighted average prices ranging from $564.12 to $570.18.
• On June 4, 2024, Casper exercised options to acquire 10,000 shares at a price of $190.59 per share and sold 9,900 shares at weighted average prices ranging from $567.05 to $573.32.
• Following these transactions, Casper directly owns 123,816.462 shares of common stock.
• Casper also indirectly owns 11,300 shares through the Alison Casper 2020 Irrevocable Trust, 43,608 shares through Floral Park Associates, Inc., and 5,000 shares through the MNC 2020 Irrevocable Trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing simply reports transactions under a pre-existing plan, which is a normal course of business. There is no indication of positive or negative sentiment.

Positives

• The transactions were executed under a pre-arranged 10b5-1 trading plan, which is a legal and transparent way for insiders to sell shares.

Industry Context

Insider transactions are common and closely monitored in the biotech and scientific instrument industry. The use of a 10b5-1 plan indicates a planned and transparent approach to managing personal stock holdings.

Comparison to Industry Standards

• Companies like Danaher, Agilent, and PerkinElmer also see regular insider trading activity.
• The use of 10b5-1 plans is a standard practice among executives at publicly traded companies to avoid accusations of insider trading.
• The volume of shares traded by Casper is within the typical range for CEOs of companies with similar market capitalization.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely minimal given the pre-planned nature of the sales.

Key Dates